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ABSTRACT 
Corneal injuries blind approximately 15 million people worldwide annually. 
Current methods of treatment have several disadvantages with respect to cost and 
availability. This study evaluated a small intestine submucosa (SIS) xenograft treatment 
for a severe corneal injury. SIS could be a favorable alternative to the current treatment 
methods, because it is inexpensive to produce and abundant where pigs are consumed. 
A severe ocular injury was created in the right eye of 5 rabbits by n-heptanol and 
mechanical debridement of the cornea and limbus. The cornea was then evaluated with 
fluorescence stain and a SIS xenograft was used for treatment. Clinical evaluations were 
made 14 days post-operatively and graded as a success if the corneal surface appeared 
smooth and avascular, or graded as a failure if the corneal surface demonstrated 
revascularization or irregularity. Histological evaluation of the cornea was done after 14 
days and graded as a success if corneal epithelium was present without conjunctival 
epithelium, or graded as a failure if conjunctival epithelium was present. 
Clinical evaluations showed smooth and avascular corneal surfaces in all 5 
injured eyes. Histological evaluation of the corneas demonstrated corneal epithelium 
without conjunctival tissue. All 5injured corneas resurfaced with corneal type 
epithelium 
This pilot study concluded that a SIS graft can be used to treat severe corneal 
mJures. 
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1.0 Background 
1.1 Corneal Injury 
Corneal injuries are a major cause of blindness worldwide; approximately 15 
million people are affected annually (1). Conservative estimates suggest that one type of 
corneal injury (corneal ulcers) blinds at least 1.5 million eyes worldwide each year (2). 
The incidence of corneal ulcers in the United States is 11 per 100,000 annually and that 
figure is increasing due to the increase in contact lens wearers (2, 3). Current treatment 
options corneal diseases include keratoplasty, keratoprothesis and amniotic membrane 
transplantation. 
1.2 Keratoplasty 
Corneal allograft transplantation (keratoplasty) is the most common and 
successful type of transplantation surgery; 32,106 were performed in the United States 
during 2004 (1, 4, 5). While this transplantation procedure remains the most popular, 
there are conditions such as ocular surface diseases, multiple graft rejections, and 
congenital corneal opacities in children, for which keratoplasty has a less than 
satisfactory outcome (1 ). In addition, individuals living in developing countries, where 
corneal blindness is most prevalent, have difficulties obtaining donor corneas (1, 5). 
During 2000, the U.S. exported 29% of all donor corneas recovered or 13,689 corneas 
(6). The corneal donor pool excludes those who have had laser in-situ keratomileusis 
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(LASIK) or photorefractive keratectomy (PRK) procedures (7). It has been projected by 
2020 that 4 7. 7 million Americans will have undergone one of these two procedures (7). 
Consequently, 28% of eligible corneal donors will be eliminated from the donor pool. 
This will further limit keratoplasty as a treatment option, especially for developing 
countries who import corneas from the U.S. (7). Furthermore, these developing countries 
may become unable to treat corneal diseases due to the lack of imported corneas and 
develop a higher incidence of blindness. 
1.3 Keratoprothesis 
One alternative to keratoplasty is keratoprosthesis. Keratoprosthesis is the 
implantation of soft materials, such as polymethyl methacylate (PMMA). However, 
problems with biologic incorporation and implant extrusion have limited their use (1). 
1.4 Amniotic Membrane 
Another alternative, human amniotic membrane (AM) has been used successfully 
to treat patients with ocular surface disorders and restore vision (8-23). Amniotic 
membrane comes from human placentas obtained after cesarean delivery. The AM is 
separated from the chorion by blunt dissection and stored at 4°C before transplantation 
(8). When AM is transplanted it is sutured to the cornea with the basement membrane 
portion facing the injured surface. The AM owes its success in part to its avascular 
cornea-like basement membrane structure, which facilitates the growth and migration of 
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epithelial cells (8, 24). However, it also has drawbacks, specifically availability of donor 
tissue. The cost of preparation and the special handling required to ship from site of 
origin to site of placement severely limit the use of amniotic membrane, especially, for 
patients at a distance from the donor (8, 26). 
1.5 Small Intestine Submucosa (SIS) 
Because of the limitations associated with AM, we began to investigate the use of 
SIS isolated from porcine as an alternative. SIS is an acellular, non-immunogenic graft. 
The submucosal layer of porcine small intestine is isolated by removing the mucosa and 
the muscularis externa leaving the submucosa and stratum compactum (27, 28, 29). 
Porcine SIS can be universally obtained from local slaughterhouses, farms or commercial 
venues. The cost to purchase SIS from a slaughterhouse and process it, as described by 
S. E. Marshall et al, is minimal compared to the cost of amniotic membrane and other 
alternative treatments (II, 26). SIS is available in areas where pigs are consumed or 
raised and can be readily prepared for application as a graft. Previous studies have 
demonstrated that SIS promotes and supports neovascularization (26). Since 
neovascularization is detrimental to the cornea, this could be a limitation for SIS as a 
corneal graft. 
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1.6 Corneal Pathophysiology 
The structure of a healthy eye and corneal transparency is crucial for visual 
acuity. The cornea is composed of5 different layers. Each layer plays a critical role in 
corneal structure and function All5 corneal layers are avascular. The thickest layer is 
the stroma. It is largely composed of collagen arranged orthogonally and is responsible 
for 66% of light refraction for visual acuity. The most superficial layer is the epithelium 
which serves as a protective layer from infection and trauma. Corneal epithelium rapidly 
regenerates from limbal stem cells (LSCs), which are located in the corneoscleral limbus 
(30). These LSC normally migrate from the peripheral aspect of the cornea centrally and 
terminally differentiate into the superficial epithelium (30). Insult and disruption to the 
LSC's will result in an ocular surface disorder (10). Ocular surface disorders can occur 
from chemical or thermal injuries, contact lens-induced keratopathy, Stevens-Johnson 
syndrome, multiple surgeries or cryotherapies to the corneosclerallimbus, hereditary 
aniridia and multiple endocrine deficiency-associated keratitis (1, 31) 
Ocular surface disorders commonly result in ingrowth of conjunctival epithelium 
( conjunctivalization), which is associated with chronic stromal inflammation and 
scarring, corneal vascularization and an inhibition of corneal epithelialization (persistent 
ocular defect) (8, 31). These manifestations are related to a loss ofLSCs. When the 
LSCs are destroyed or surgically removed conjunctival epithelial cells surrounding the 
cornea will invariably resurface the cornea (32-36). Corneal and conjunctival epithelia 
are two phenotypically distinct cell lines. This is why re-epithelialization of the cornea 
by conjunctival cells is accompanied by chronic inflammation, persistent epithelial 
defects, stromal scarring, and neovascularization (8, 10, 31, 35). When these conditions 
disrupt the structure of the healthy eye and impede the entry of light, partial or complete 
blindness will result. 
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Successful autologous LSC transplants onto AM have been reported 
experimentally and clinically (21 , 23, 24, 25). However, when both eyes sustain LSC 
damage, there is no autologous source ofLSCs to transplant. It was hoped that an AM 
would facilitate a process known as conjunctival transdifferentiation to treat this LSC 
deficency (8, 32, 37). Conjunctival transdifferentiation was noted to occur when 
conjunctival epithelium overgrows a corneal basement membrane and is morphologically 
transformed into corneal epithelium (32, 34, 37). However, in later studies forniceal 
conjunctival cells cultured on AM failed to transdifferentiate into corneal epithelium, 
undermined the classic view (38). This dispute concept was shifting against conjunctival 
transdifferentiation when preliminary research for this study commenced (24 ). 
Subsequently, this investigation changed its aim from determining whether SIS could 
facilitate conjunctival transdifferentiation to whether SIS could facilitate corneal re-
epithelialization. The prior hypothesis would have required the injurious creation of a 
limbal stem cell deficiency which invariably results in an ocular defect and then a 
subsequent surgery about 3 weeks later to treat the ocular surface defect with a SIS 
xenograft (8). Based on the alternative hypothesis we chose to study the effect of SIS on 
an acuty corneal injury. This also minimizes discomfort to the rabbit by promptly 
treating the injury and avoiding more than one surgery. 
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1. 7 Animal Research 
Animal research is a controversial area of science that is constantly changing and 
improving to insure humane practices and minimal animal usage. The PCOM 
Institutional Animal Care and Use Committee (IACUC) reviewed the methods herein, to 
insure humane treatment and compliance with federal regulations. In addition, this 
protocol is in accordance with the Association for Research in Vision and Ophthalmology 
(ARVO) statement for use of animals in ophthalmic and visual research. 
Pain management was designed to minimize distress and discomfort without 
interfering with the study. While it is difficult to prevent discomfort, the pain 
management in this study exceeds the standards implemented in human patients. This 
investigation utilized local, general anesthesia, and nonsteroidal anti-inflammatory to 
maximize comfort. Local anesthesia or Proparacaine was used to block sensory receptors 
in the eye pre- and intra-operatively. It was not used post-operatively to avoid toxic 
keratitis, which would have impeded healing of the corneal epithelium. Another option, 
peri bulbar anesthesia was considered, but decided against due to possible trigeminal 
nerve injury and subsequent neurotrophic keratitis, which would result in a corneal ulcer. 
Rabbits are used extensively for ophthalmic research, and are sanctioned for such 
use by the Association for Research in Vision and Ophthalmology (see www.arvo.org 
under research). In addition, similar procedures, to those used herein, for creating an 
ocular surface disorder in the New Zealand white rabbit have been well studied and 
developed (37, 39). It was necessary to use a live animal model to evaluate the 
propensity of SIS to facilatate corneal epithelialization without causing an immunogenic 
response to the graft. This type of study could not be carried out in non-animal 
alternatives. No in-vitro model can simulate in-vivo injuries and repairs to the ocular 
surface. 
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2.0 Hypothesis and Rationale 
SIS zenografts would have global application for treatment of ocular surface 
disorders if they can be shown to facilitate corneal re-epithelization without eliciting an 
immune response or neovascularization. This pilot study is the first stardardized 
investigation to explore the healing potential of a SIS zenograft in a New Zealand white 
rabbit, which has a comparable eye structure and physiology to that of a human. 
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3.0 Goals and Specific Aims 
The goals of the study were to (1) develop an ocular surface injury in a rabbit 
model (2) repair the ocular surface injury with a SIS zenograft, (3) identify success or 
failure clinically and histologically, and (4) execute 1, 2 and 3 while minimizing distress 
and discomfort to the animals. To achieve these goals, specific aims were established 
and are as follows: 
1. Produce an ocular injury by instilling n-heptanol into one eye of each rabbit and 
then mechically removing the corneal epithelium 2mm beyond the limbus. 
2. Establish the presence of an ocular surface injury by instilling fluorescene into 
the injured eye and using an ophthalmoscope with a blue filter for visualization. 
3. Monitor post-operative distress by clinical observations for tearing, wincing, 
vocalization, excessive rubbing or biting, and dietary and behavioral changes. 
4. Clinically examine pupillary reflexes bilaterally at 3, 10 and 14 days post-
operatively with an ophthalmos.cope. 
5. Histologically evaluate the both injured and non-injured eyes with eosin-
hematoxylin and mucin stain. 
6. Develop a conservative and effective pain management method utilizing the 
following medications: Buprenorphine, Isoflurane, Ketamine, Meloxicam, 
Proparacaine, and Xylazine. 
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4.0 Method and Materials 
4.1 Graft Preparation 
Fresh porcine jejunum was obtained from a USDA approved slaughterhouse 
(Bristol Pork Co. Inc., Bristol, P A). The jejunum was identified and isolated. A remnant 
of the mesentery was retained to preserve orientation. The fresh jejunum was rinsed with 
warm tap water and then washed a second time with saline. After rinsing it was stored in 
a 10% Gentamycin saline solution at 4 degrees Celsius for no more than a week. The 
10% Gentamycin saline solution was changed every 24 hours. 
Approximately 24 hours prior to graft transplant the jejunum was subdivided and 
transected longitudinally. The serosal surface was exposed and stripped off with pointed 
forceps. The mucosal surface was exposed and removed by mechanical scrapping with 
the edge of a scalpel handle, which isolated the submucosal layer. 
4.2 Corneal Injury and Transplantation of SIS Xenograft 
4.2.1 Pre-Surgical Protocol 
5 New Zealand white male rabbits weighing 2.5-3.0 kg were fasted and weighed 
prior to surgery. Induction was achieved with an intramuscular (IM) injection of 
Ketamine, 35 mg/Kg and Xylazine, 5 mg/kg. Proparacaine 0.5% ophthalmic solution 
(three drops) was administered as well as Meloxicam 0.2mg/kg subcutaneously (SC). A 
surgical plane of anesthesia was maintained by administration ofisoflurane 1-3% to 
effect via a cone mask fitted over the nose and mouth. Maintenance of the plane was 
monitored with evoked responses and pulse oximetry. 
4.2.2 Intra-Operative Protocol: Corneal Debridement 
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A sterile field was established and the rabbit was draped in the usual fashion. The 
right eyelid (OD) was gently retracted by a speculum and four 6-0 Proline sutures were 
placed in the palpebral conjunctiva and secured to the drape with hemostats. The right 
eye was instilled with n-Heptanol for 1 to 2 minutes. Under an operating microscope the 
corneal epithelium was removed by blunt dissection with a # 15 scalpel blade from the 
central cornea to 3mm beyond the limbus. The cornea was then rinsed with sterile 
isotonic saline. Approximately 2 drops of fluorescein (Fluress, Akorn Laboratories) were 
instilled and visualized with a cobalt blue light source (Fig. 1). Following a satisfactory 
debridement the eye was again irrigated with sterile isotonic saline. 
4.2.3 Intra-Operative Protocol: Xenograft Transplantation 
The SIS xenograft was then measure to size and cut with curved iris scissors. 
Under an operating microscope the SIS was placed on the cornea. A cellulose surgical 
spear was placed on both serosa and mucosa surfaces of the SIS xenograft (Fig. 2). The 
shiny surface (basement membrane) of the SIS xenograft was placed directly on the 
cornea. In a cruciate fashion eight 10-0 Nylon sutures where place in an interrupted 
fashion at 12, 6, 3, 9, 2, 8, 4, and 10 clock hours to tact the SIS xenograft to the 
comeoscleral region (Fig. 3). The redundant edges of the SIS xenograft were excised 
with curved iris scissors. A second drop ofProparacaine 0.5% (2 drops) was 
administered and again irrigated with sterile isotonic saline. Maxitrol ointment was 
applied. Lastly, the four 6-0 Proline sutures within the palpebral conjunctiva and 
speculum were removed. Buprenorphine 0.05mg/kg IM was given 30 minutes prior to 
emergence from anesthesia. 
4.2.4 Post-Operative Protocol 
The animal was visually monitored until able to assume a dorsal recumbent 
position by the principal investigator in the surgical facility. Thereafter, the animal was 
transferred to the LAR facility. Meloxicam 0.2 mg/ml SC was given 8 hours after the 
initial dose. 
12 
Pain was evaluated according to the following criteria: 1) abnormal food and 
water intake, 2) restless behavior patterns, 3) vocalizations, 4) excessive rubbing or 
biting. Vital signs were measured, the surgical incision site was evaluated for bleeding, 
graft detachment, infection, and corneal perforation. Maxitrol ointment was applied once 
daily for 10 days. Pupillary reflexes were checked in both eyes at 3, 10 and 14 days post-
operatively with an ophthalmoscope. 
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4.3 Comeoscleral Tissue Recovery 
The animals were induced with Ketamine (35mg/kg, IM), and Xylazine (5mg/kg, 
IM). The animals were euthanized with intravenous injection ofEuthasol (2 ml). Both 
eyelids were gently retracted by a speculum. A deep initial incision was made 3 to 5 mm 
from the limbus or SIS xenograft with a Bard-Parker #15 blade. A sclera incision was 
made 360° around the cornea to include the graft if present with cured iris scissors. The 
corneoscleral tissue was gentle lifted from the global. The tissue was then placed in 
formaldehyde. 
4.4 Tissue Sample Preparation 
The corneoscleral specimens were paraffm embedded and sectioned by 
microtome at 6 Jlffi The sections were made to include the peripheral limbus and the 
center of the cornea. Tissue sections were mounted on slides and stained using Periodic 
Acid Schiffs (PAS) reagent. The protocol and reagents were obtained from Electron 
Microscopy Sciences (Hatfield, P A). 
4.5 Corneal Evaluation 
Gross clinical evaluations were made 14 days post-operatively and graded as a 
success if the corneal surface appeared smooth and avascular, or graded a failure if the 
corneal surface demonstrated revascularization or irregularity. 
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Histological evaluation of corneas at 14 days post-operatively was graded as a 
success if corneal epithelium was present without conjunctival epithelium, or graded as a 
failure if conjunctival epithelium was present. 
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5.0 Results 
5.1 Clinical Observations 
5.1.1 Cornea 
Following the intra-operative chemical and mechanical corneal debridement, 
fluorescein uptake, and a non-smooth corneal surface was observed in all injured eyes. 
Post-operative observations were conducted daily with an ophthalmoscope. The corneal 
surfaces were smooth and clear at post-operative day 14 in all five rabbits (Tab. 1). No 
neovascularization, excessive tearing, pus, conjunctivitis, or evidence of pathology was 
noted bilaterally. 
5.1.2 Pupillary 
Pupillary exams were conducted at post-operative days 3, 10 and 14 with an 
ophthalmoscope. Bilateral consensual and direct pupillary responses were noted, while 
the SIS was intact (Tab. 1). 
5.1.3 Graft 
Daily observations regarding the graft attachment and placement were made. At 
post-operative day 4 the medial aspect, clock hours 3 and 4, of the sutures were detached 
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from the corneoscleral region in all five rabbits. At post-operative day 10 the SIS graft 
remain intact but was now detached from the inferior and medial aspects or clock hours 
3, 4 and 6 in all five rabbits. At post-operative day 14 the SIS graft remained intact over 
the central corneal surface but now detached from the superior or 12 o'clock suture. 
The cellulose surgical spears adhered only to the basement membrane surface of 
the SIS (Fig. 2). 
5.2 Histological Observations 
Microscopic examination showed corneal epithelium over the entire SIS 
xenograft eye in all5 specimens. However, the basal layer in the non-injured eye was 
thicker and slightly more stratified 5-6 cell layers thick (Fig. 4). In 4 out of 5 injured 
eyes the corneal epithelium was approximately 5 layers thick (Fig. 8). One injured eye 
had approximately 4 layers (Fig. 6). The presence of goblet cells was not seen on the 
corneal surfaces of all5 injured eyes. Mucin containing goblet cells were seen 
peripherally in conjunctival tissue of these injured eyes (Fig. 7). Additionally, suture-
induced inflammatory changes were noted only around the 10-0 Nylon. 
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6.0 Discussion 
6.1 Clinical Observations 
6.1.1 Cornea 
The intra-operative fluorescein was used to establish a successful debridement of 
corneal epithelium However, discerning the extent of corneallimbal stem cell damage is 
challenging without establishing a persistent ocular defect. In prior studies persistent 
ocular defects were established by not treating the injured eyes (8). To avoid multiple 
surgeries and excessive discomfort to the animals we elected to treat all injuries during 
the first and only surgery. The combined mechanical and n-heptanol debridement 
method of injury has been developed in prior studies (8, 31, 33). These injuries 
invariably result in conjunctival migration and persistent ocular defects (8, 31, 33). 
Successful repair was clinically observed in all five injured corneas. Corneal 
surface damage caused by chemical injury is devastating and difficult to manage in 
human patients (9). The noted smooth and avascular surface, clear stroma and good 
vision (as judged by clear iris detail) is preliminary evidence that a SIS xenograft is an 
efficacious treatment for corneal injuries. 
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6.1.2 Pupillary 
The injuries developed in this study do not affect pupillary reflex. However, the 
opacity of any membrane superficial to the pupil could affect this reflex. The SIS 
xenograft was transparent enough to permit consensual and direct pupillary reflexes and 
normal visually-directed behavior. The transparency of the SIS xenograft is helpful in 
maintaining the rabbits normal diurnal cycle, feeding, and playing habits. However, the 
intact graft does not allow assessment of visual acuity by ophthalmoscope or retinoscopy. 
These results suggest that a prolonged application of the SIS xenograft is possible, based 
on how well it was tolerated in this study. 
6.1.3 Graft 
Corneal re-epithelialization depends largely on the presence of a basement 
substrate to facilitate its migration over the surface (9). The SIS xenograft in this 
investigation appears to facilitate re-epithelialization similar to a normal corneal 
basement membrane, or AM graft. The close proximity of the SIS xenograft is crucial 
for the re-epithelialization and the reduction of inflammation. The corneal epithelium 
migrates centrally, covering approximately 1mm2/hour (31, 40). The detached graft 
observed at post-operative day 14 remained intact long enough to facilitate the centripetal 
migration of corneal epithelium However, the detached graft is a less than desired 
outcome. Graft detachment was due to the repetitive mechanical trauma caused by the 
nictitating membrane and a lack of sutures. It is possible that the suture-induced 
inflammation may have played, even though Nylon sutures were used to decrease 
inflammation associated with absorbable sutures. 
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The use of a cellulose spear as a non-abrasive absorbent is common in 
ophthalmology. When using AM the surgeon will apply the cellulose spear to the surface 
of the graft. The cellulose spear with only adhere to the shiny or basement membrane 
surface. This is another technique to determine graft orientation. The basement 
membrane surface will best facilitate re-epithelialization. This investigation 
demonstrated that the cellulose spear preferentially adhered to the SIS basement 
membrane (Fig. 2). 
6.2 Histological Observations 
The normal cornea has a non-keratinizing, stratified squamous epithelium that has 
5-6 cell layers. When mechanical debridement of the corneal and limbal epithelium is 
untreated, a conjunctival cell migration over the cornea occurs in 1 to 2 weeks (31 ). The 
SIS xenograft in this study appeared to facilitate re-epithelialization with corneal 
epithelium in all five cases. Interestingly, at 14 days post graft placement most corneas 
had stratified into normal appearing epithelium In 4 out of 5 eyes the corneal epithelium 
was approximately 5 layers thick (Fig. 8). One injured eye had approximately 4 layers 
thick (Fig. 6). Perhaps the combination of mechanical and chemical injury is responsible 
for the delayed epithelial stratification. Although the suture-induced inflammation 
showed polymorphonuclear cells, none of the injured eyes demonstrated an immune 
response to the SIS xenograft. These polymorphonuclear cells were well contained 
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around the peripheral suture sites. Additionally, despite the propensity of SIS to facilitate 
neovascularization in prior studies, no vessels were seen on the cornea (29). 
7.0 Future Considerations 
This is the first investigation of efficacy of a SIS xenograft for treatment of an 
ocular surface injury. The finding of re-epithelialization without inflammatory change 
suggests a potential role for SIS xenograft in treatment of human corneal surface 
disorders. Further investigations will be needed prior to human clinical trials, including 
studies to reveal the dynamic utility of the SIS graft in corneal repair. An investigation of 
explanted limbal stem cells, expanded on a SIS graft and then transplanted into an injured 
eye would have particular merit. 
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APPENDIX A: Figures 
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FIGURE 1 
Fluorescein Instilled in the Injured Cornea 
Fluorescein staining of the cornea followed mechanical and chemical debridement. A 
blue filtered light was used to reveal the fluorescent green stain over the denuded surface 
(see white arrows). A# 15 scalpel blade (see black arrow) is seen to the right of the 
cornea. This was reapplied to remove any remaining epithelium. This figure was 
magnified x 2. 
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FIGURE2 
SIS Adhering to Cellulose Spear 
A cellulose spear was applied to the SIS graft to indicate orientation. It would only 
adhere to the basement membrane surface. This technique is used with AM and also 
adheres to its basement membrane surface. This figure was magnified x 2.5. 
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FIGURE3 
SIS Xenograft on Cornea 
This is the post-operative graft on the cornea. The SIS xenograft was sutured to the 
cornea with 10-0 Nylon. The arrows are pointing to the sutures. 
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FIGURE4 
Normal Corneal Epithelium 
This is a non injured cornea. The cornea consists of approximately 5 layers of stratified 
squamous epithelium; 1 columnar basal cell layer (B), 2-3 wing cell layers (W) and 1-2 
layers of superficial cells (S). Present within the stroma are air spaces, which resulted 
from the tissue being bent during the formaldehyde fixation (PAS, x400). 
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FIGURES 
Normal Conjunctival 
The conjunctiva consists of several layers of columnar epithelial cells. The conjunctival 
basal layer is poorly defined. Conjunctival epithelium is interspersed with mucin 
containing goblet cells, which are indicated by arrows (PAS x400). 
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FIGURE6 
Injured Cornea Treated by SIS #1 
This SIS treated cornea had approximately 4 cell layers of epithelium. The basal layer 
(B) in this figure is a well organized single layer, which distinguishes it from conjunctival 
epithelium The wing layer (W) is less developed in this figure when compared to the 
non-injured corneas. The superficial layer (S) is well developed in this figure (PAS 
x400). 
Co1neal 
Epiheliu1n 
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FIGURE7 
Injured Conjunctival Tissue over the Sclera 
The ocular injury was made beyond the corneal limbus. The injured conjunctiva had 
fewer cell layers. Injured conjunctival epithelium did not appear to stratify as quickly as 
corneal epithelium. Goblet cells are still noted (by arrows). Blood vessels are common 
to the sclera and conjunctiva. An asterisk indicates the lumen of a blood vessel (PAS 
x200). 
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FIGURES 
injured Cornea Treated by SIS # 2 
This SIS treated cornea had approximately 5 cell layers of epithelium All 3 layers of 
corneal epithelium are well developed and appear similar to the non-injured tissue. The 
basal layer (B) epithelium appears uniform and well organized. The wing layer (W) and 
superficial layer (S) are well developed (PAS x200). 
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APPENDIX B: Table 
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TABLE 1 
Summary of Post-Operative Clinical Evaluations 
Pupillary reflexes and general examinations were conducted at post-operative days 3, 10 
and 14. Discharge and edema are signs of infection or graft rejection. At post-operative 
day 14 corneal surfaces were evaluated post-mortem for smoothness and clarity. Corneal 
surfaces were not evaluated at post-operative days 3 and 10, due to possible discomfort to 
the animals. An ophthalmoscope was used to examine bilateral pupillary reflexes, 
corneal transparency, and corneal smoothness. The presences of vessels constitute 
vascularization. An ophthalmoscope was used to inspect the peripheral aspect of the 
corneas where vascularization starts. Pupillary reflexes remained intact and corneal 
surfaces remained avascular in all 5 animals. 
40 
Table 1. Summary of post-operative clinical evaluations 
Day 3 Day 10 Day 14 
Discharge 0 0 0 
Edew..a 0 0 0 
Pupillary Reflexes 5 5 5. 
Direct and Consensual 
Opacity 0 0 0 
Vascularization 0 0 0 
Smooth Surface n/a n/a 5 
0, absence of signs in all animals; 5, present in all five animals; and n/a if exam not done. 
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